Metabolite profiling of olive oil and thyme phenols after a sustained intake of two phenol-enriched olive oils by humans: Identification of compliance markers

Food Research International

Volumn 65, Issue PA, 2014, Pages 59-68

  Rubió, Laura ^a   Farràs, Marta ^b   de La Torre, Rafael ^b,c   Macià, Alba ^a   Romero, Maria Paz ^a   Valls, Rosa M ^d   Solà, Rosa ^d   Farré, Magí ^b,c   Fitó, Montserrat ^b   Motilva, Maria José ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Compliance biomarkers; Human intervention; Olive oil; Phenolic metabolites; Thyme

Indexed keywords

EID: 84908667982     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2014.05.009     Document Type: Article

References (39)

1. Austgulen L.T., Solheim E., Scheline R.R. Metabolism in rats of p-cymene derivatives: Carvacrol and thymol. Pharmacology and Toxicology 1987, 61(2):98-102.
2. Baba S., Osakabe N., Natsume M., Terao J. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid. Life Sciences 2004, 75(2):165-178.
3. Baba S., Osakabe N., Natsume M., Yasuda A., Muto Y., Hiyoshi K., et al. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. European Journal of Nutrition 2005, 44(1):1-9.
4. Covas M.I., de la Torre K., Farré-Albaladejo M., Kaikkonen J., Fitó M., López-Sabater C., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radical Biology & Medicine 2006, 40(4):608-616.
5. Covas M.I., Nyyssönen K., Poulsen H.E., Kaikkonen J., Zunft H.-J.F., Kiesewetter H., et al. The effect of polyphenols in olive oil on heart disease risk factors: A randomized trial. Annals of Internal Medicine 2006, 145(5):333-341.
6. De la Torre R., Covas M.I., Pujadas M.A., Fitó M., Farré M. Is dopamine behind the health benefits of red wine?. European Journal of Nutrition 2006, 45(5):307-310.
7. Del Rio D., Rodriguez-Mateos A., Spencer J.P.E., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants and Redox Signaling 2013, 18(14):1818-1819.
8. Edwards D.J., Rizk M. Conversion of 3,4-dihydroxyphenylalanine and deuterated 3,4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain. Journal of Neurochemistry 1981, 36(5):1641-1647.
9. EFSA Panel on Dietetic Products, N.and A.(NDA) Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA Journal 2011, 9(5):2170. (36 pp.). 10.2903/j.efsa.2011. 2170.
10. García-Villalba R., Carrasco-Pancorbo A., Nevedomskaya E., Mayboroda O.A, Deelder A.M., Segura-Carretero A., et al. Exploratory analysis of human urine by LC-ESI-TOF MS after high intake of olive oil: Understanding the metabolism of polyphenols. Analytical and Bioanalytical Chemistry 2010, 398(1):463-475.
11. Goldstein D.S., Eisenhofer G., Kopin I.J. Sources and significance of plasma levels of catechols and their metabolites in humans. Journal of Pharmacology and Experimental Therapeutics 2003, 305(3):800-811.
12. Hollman P.C.H. Absorption, bioavailability, and metabolism of flavonoids. Archives of Physiology And Biochemistry 2004, 42(s1):74-83.
13. Huang W., Niu H., Gu Y. Metabolic kinetics of tert-butylhydroquinone and its metabolites in rat serum after oral administration by LC/ITMS. Lipids 2008, 43(8):757-763.
14. Kay C.D. The future of flavonoid research. British Journal of Nutrition 2010, 104(Suppl. 3):S91-S95.
15. Kay C.D., Hooper L., Kroon P.A., Rimm E.B., Cassidy A. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomised controlled trials of flavonoid-rich food products. Molecular Nutrition & Food Research 2012, 56(11):1605-1616.
16. Kohlert C., Schindler G., März R.W., Abel G., Brinkhaus B., Derendorf H., et al. Systemic availability and pharmacokinetics of thymol in humans. The Journal of Clinical Pharmacology 2002, 42(7):731-737.
17. Krogholm K.S., Bysted A., Brantsæter A.L., Jakobsen J., Rasmussen S.E., Kristoffersen L., et al. Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. British Journal of Nutrition 2012, 108(10):1904-1912.
18. Krogholm K.S., Haraldsdóttir J., Knuthsen P., Rasmussen S.E. Urinary total flavonoid excretion but not 4-pyridoxic acid or potassium can be used as a biomarker for the intake of fruits and vegetables. Journal of Nutrition 2004, 134(2):445-451.
19. Marrugat J., Covas M.I., Fitó M., Schröder H., Miró-Casas E., Gimeno E., et al. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation-A randomized controlled trial. European Journal of Nutrition 2004, 43(3):140-147.
20. Medina-Remón A., Tresserra-Rimbau A., Arranz S., Estruch R., Lamuela-Raventos R.M. Polyphenols excreted in urine as biomarkers of total polyphenol intake. Bioanalysis 2012, 4(22):2705-2713.
21. Mennen L.I., Sapinho D., Ito H., Bertrais S., Galan P., Hercberg S., et al. Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. British Journal of Nutrition 2006, 96(1):191-198.
22. Minuti L., Pellegrino R.M., Tesei I. Simple extraction method and gas chromatography-mass spectrometry in the selective ion monitoring mode for the determination of phenols in wine. Journal of Chromatography. A 2006, 1114(2):263-268.
23. Miro-Casas E., Covas M.-I., Farre M., Fito M., Ortuño J., Weinbrenner T., et al. Hydroxytyrosol disposition in humans. Clinical Chemistry 2003, 49(6 Pt 1):945-952.
24. Miró-Casas E., Farré Albaladejo M., Covas M.I., Rodriguez J.O., Menoyo Colomer E., Lamuela Raventós R.M., et al. Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Analytical Biochemistry 2001, 294(1):63-72.
25. Nakazawa T., Ohsawa K. Metabolism of rosmarinic acid in rats. Journal of Natural Products 1998, 61(8):993-996.
26. Nielsen S.E., Freese R., Kleemola P., Mutanen M. Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiology, Biomarkers and Prevention 2002, 11(5):459-466.
27. Pinto J., Paiva-Martins F., Corona G., Debnam E.S., Jose Oruna-Concha M., Vauzour D., et al. Absorption and metabolism of olive oil secoiridoids in the small intestine. The British Journal of Nutrition 2011, 105(11):1607-1618.
28. Puiggròs F., Solà R., Bladé C., Salvadó M.-J., Arola L. Nutritional biomarkers and foodomic methodologies for qualitative and quantitative analysis of bioactive ingredients in dietary intervention studies. Journal of Chromatography. A 2011, 1218(42):7399-7414.
29. Rubió L., Macià A., Castell-Auví A., Pinent M., Blay M.T., Ardévol A., et al. Effect of the co-occurring olive oil and thyme extracts on the phenolic bioaccessibility and bioavailability assessed by in vitro digestion and cell models. Food Chemistry 2014, 149:277-284.
30. Rubió L., Motilva M.J., Macià A., Ramo T., Romero M.P. Development of a phenol-enriched olive oil with both its own phenolic compounds and complementary phenols from thyme. Journal of Agricultural and Food Chemistry 2012, 60(12):3105-3112.
31. Rubió L., Serra A., Macià A., Borràs X., Romero M.P., Motilva M.J. Validation of determination of plasma metabolites derived from thyme bioactive compounds by improved liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2012, 905:75-84.
32. Serra A., Rubió L., Macià A., Valls R.-M., Catalán U., de la Torre R., et al. Application of dried spot cards as a rapid sample treatment method for determining hydroxytyrosol metabolites in human urine samples. Comparison with microelution solid-phase extraction. Analytical and Bioanalytical Chemistry 2013, 405(28):9179-9192.
33. Spencer J.P.E., Abd El Mohsen M.M., Minihane A.M., Mathers J.C. Biomarkers of the intake of dietary polyphenols: Strengths, limitations and application in nutrition research. The British Journal of Nutrition 2008, 99(1):12-22.
34. Suárez M., Romero M.P., Macià A., Valls R.M., Fernández S., Solà R., et al. Improved method for identifying and quantifying olive oil phenolic compounds and their metabolites in human plasma by microelution solid-phase extraction plate and liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009, 877(32):4097-4106.
35. Thalhamer B., Buchberger W., Waser M. Identification of thymol phase I metabolites in human urine by headspace sorptive extraction combined with thermal desorption and gas chromatography mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2011, 56(1):64-69.
36. Vázquez Roncero A., Janer Del Valle C., Janer Del Valle M.L. Determinación de los polifenoles totales del aceite de oliva. Grasas y Aceites 1973, 24(6):350-357.
37. Visioli F., Galli C., Bornet F., Mattei A, Patelli R., Galli G., et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters 2000, 468(2-3):159-160.
38. Vissers M.N., Zock P.L., Katan M.B. Bioavailability and antioxidant effects of olive oil phenols in humans: A review. European Journal of Clinical Nutrition 2004, 58(6):955-965.
39. Weinbrenner T., Torre R.De, Saez G.T., Rijken P., Tormos C., Coolen S. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. Journal of Nutrition 2004, 134(9):2314-2321.